Laboratory News and Research

RSS

New imaging method reveals the inner workings of a family of light-sensing molecules

Using an innovative new imaging technique, researchers at Weill Cornell Medicine have revealed the inner workings of a family of light-sensing molecules in unprecedented detail and speed. The work could inform new strategies in the burgeoning field of optogenetics, which uses light pulses to alter the activity of individual neurons and other cells.

27 Jan 2022

UofL professor wins $6.7 million grant to investigate how metals cause lung cancer

For nearly three decades, John Pierce Wise Sr. has investigated the connection between exposure to metals and cancer, working both in the lab and in the field, reporting significant discoveries about the effects of metals on chromosomes in lung cancer and how those effects differ in humans and in whales.

27 Jan 2022

National identities play a significant and positive role in battling COVID-19 pandemic

Identification with one's nation predicts both greater engagement with public health behaviors, such as masking and social distancing, and support for public health policies, finds an analysis of attitudes across 67 countries.

27 Jan 2022

COVID-19 vaccination does not affect fertility outcomes in patients undergoing in-vitro fertilization

Vaccination against COVID-19 did not affect fertility outcomes in patients undergoing in-vitro fertilization (IVF), a new study has found.

27 Jan 2022

Study explores how cannabis use affects driving performance

The steady rise in the use of cannabis - 18 states have legalized recreational use, 13 have decriminalized its use and 36 have medical cannabis laws - has provoked myriad questions and concerns about public health implications, including how cannabis may affect the abilities, real and perceived, of drivers under the influence.

26 Jan 2022

CDC tells pharmacies to give 4th covid shots to immunocompromised patients

The Centers for Disease Control and Prevention reached out to pharmacists Wednesday to reinforce the message that people with moderate to severe immune suppression are eligible for fourth covid shots.

26 Jan 2022

‘Lefty’ protein pumps the brakes during initial stages of embryo differentiation

A protein known as Lefty pumps the brakes as human embryos begin to differentiate into the bones, soft tissues and organs that make us.

25 Jan 2022

Serum biomarkers for SARS-CoV-2 reinfection identified in rhesus macaques

Many experts now predict that COVID-19, which so far has killed more than 5.5 million people worldwide, will remain endemic as new, infectious variants of SARS-CoV-2 emerge.

25 Jan 2022

Humoral correlate of protection for SARS-CoV-2 may reduce COVID-19 infection risk

In a new study, a team of researchers reviewed the published literature to find evidence for humoral SARS-CoV-2 correlate of protection (CoP).

25 Jan 2022

New therapeutic approach offers hope to treat obesity and related metabolic disorders

Scientists at Nanyang Technological University, Singapore (NTU Singapore) have developed a new therapeutic approach to obesity and related metabolic disorders that in laboratory experiments demonstrated a significant reduction in body fat, body weight, and improvement in the blood markers that accompany these disorders.

25 Jan 2022

Study opens the door to a new approach to attacking herpesviruses

A new study published this week in mBio, an open access journal of the American Society for Microbiology, has opened the door to a new approach to attacking herpesviruses.

25 Jan 2022

Study finds poorer outcomes after ICU discharge in patients with alcohol-associated cirrhosis

Patients with alcohol-associated cirrhosis have poorer outcomes after ICU discharge, compared to patients with cirrhosis linked to other causes, according to new Mayo Clinic research.

25 Jan 2022

Low-cost test could open new avenues for earlier diagnosis, treatment of rare genetic disorders

A newly developed test to screen for three rare genetic disorders simultaneously in newborns was feasible, reliable and scalable, according to a new study.

24 Jan 2022

Neurological complications of the SARS-CoV-2 vaccine

In a study published in the latest issue of the journal Neurological Sciences, a team of researchers described a three-patient case series presenting with neurological manifestations after the coronavirus disease 2019 (COVID-19) vaccination, followed by a literature review, to propose hypotheses on how neurological symptoms might develop after vaccination.

24 Jan 2022

Common cystic fibrosis drugs work by directly aiding the protein folding process, study shows

Protein misfolding is a likely culprit in many degenerative disorders. Cystic fibrosis, for instance, is caused by mutations in the CFTR gene that prevent the eponymous protein from assuming its proper configuration.

24 Jan 2022

Novel gene therapy for diseased muscle fiber repair

In this interview, News-Medical speaks to Dr. Jyoti K. Jaiswal about his latest research into gene therapies for limb-girdle muscular dystrophy 2B.

24 Jan 2022

PFAS found in high levels in anti-fogging sprays

We speak to Professor Heather Stapleton and Dr. Nicholas Herkert about their latest research that led to the discovery of high levels of PFAS in anti-fogging sprays.

24 Jan 2022

Gene replacement therapy could help mend a broken heart, study suggests

How can you mend a broken heart? According to researchers from Japan, in some cases gene replacement therapy just might do the trick.

24 Jan 2022

Study shows how SARS-CoV-2 Omicron evades our immune response and remains infective

A recent study published in the journal Science brings a detailed chemical and molecular perspective on the improved evasion of antibodies against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the retention of strong interactions with the receptor as two principal factors underneath the notorious transmissibility of the SARS-CoV-2 Omicron variant.

23 Jan 2022

Rapid, highly accurate drug detection vital to reducing the adverse impacts of addiction

Rapid, accessible and highly accurate detection of addictive substances such as opiates and cocaine is vital to reducing the adverse personal and societal impacts of addiction, something current drug detection systems can take too long to provide.

22 Jan 2022

Laboratory News and Research

New imaging method reveals the inner workings of a family of light-sensing molecules

UofL professor wins $6.7 million grant to investigate how metals cause lung cancer

National identities play a significant and positive role in battling COVID-19 pandemic

COVID-19 vaccination does not affect fertility outcomes in patients undergoing in-vitro fertilization

Study explores how cannabis use affects driving performance

CDC tells pharmacies to give 4th covid shots to immunocompromised patients

‘Lefty’ protein pumps the brakes during initial stages of embryo differentiation

Serum biomarkers for SARS-CoV-2 reinfection identified in rhesus macaques

Humoral correlate of protection for SARS-CoV-2 may reduce COVID-19 infection risk

New therapeutic approach offers hope to treat obesity and related metabolic disorders

Study opens the door to a new approach to attacking herpesviruses

Study finds poorer outcomes after ICU discharge in patients with alcohol-associated cirrhosis

Low-cost test could open new avenues for earlier diagnosis, treatment of rare genetic disorders

Neurological complications of the SARS-CoV-2 vaccine

Common cystic fibrosis drugs work by directly aiding the protein folding process, study shows

Novel gene therapy for diseased muscle fiber repair

PFAS found in high levels in anti-fogging sprays

Gene replacement therapy could help mend a broken heart, study suggests

Study shows how SARS-CoV-2 Omicron evades our immune response and remains infective

Rapid, highly accurate drug detection vital to reducing the adverse impacts of addiction

A guide to density measurement excellence eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo